MARKETS / BALCAO / Health care / Medical devices and instruments / ADMT

BALCAO · ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS · SMALL CAP

ADM Tronics Unlimited, Inc. ADMT

16 fiscal years on record · USD · FY2025 reported · SEC filings only

Revenue

$3.3M

▲ 4.7% YoY

Net income

$-100,374

Slide the table for earlier years · "·" marks a figure not available in our data for that year.

In brief

What this company does

The Company is a technology-based developer and manufacturer of diversified lines of products and derives revenue from the production and sale of electronics for medical devices and other applications; environmentally safe chemical products for industrial, medical and cosmetic uses; and, research, development, regulatory and engineering services. The Company is a corporation organized under the laws of the State of Delaware on November 24, 1969. We develop and manufacture electronic technologies for non-invasive, electrotherapeutic and diagnostic medical devices as well as for veterinary and other applications. The Company derives revenues from contract manufacturing of electronic medical and other devices from non-affiliated customers. We develop, manufacture, and sell chemical products to industrial users. Through its Antistatic Industries division, the Company develops, manufactures, and distributes conductive and antistatic products for commercial and industrial applications. We believe that our present insurance coverage is adequate for the types of products we currently market.

Written from the business description in ADM Tronics Unlimited, Inc.'s annual report to the U.S. Securities and Exchange Commission, filed 10 July 2026. Every sentence was checked against that document before publication.

Growth

USD 3.3M

Revenue, FY2025 · full 16-year series below

Revenue $M Net income $M

FY2025 · Revenue 3.3 · Net income -0.1

2.0M4.0M-0.5M-1.0M

201020132016201920222025

Compound annual growth

Revenue

−3.1%

+1.6%

−2.9%

+7.1%

3 yrs

5 yrs

10 yrs

15 yrs

Revenue compounded at +1.6% a year over the five years to FY2025.

Compound annual rates per period — left blank where that exact year isn't on file, the series crosses a loss, or (per-share rows) a split falls inside the window.

Profitability

−3 cents

lost on every revenue dollar

Operating margin Net margin

FY2025 · Operating -4.8% · Net -3.0%

10%20%-20%-40%

201020172025

ROE

FY2025 · ROE -16.2%

50%-50%-100%

201020172025

Three returns, three denominators.

Return on equity-16.2%

Return on assets-5.1%

Return on capital employed-18.1%

Gross margin40.5%

Operating margin-4.8%

Net margin-3.0%

EBITDAUSD -152,280.00

Each USD of equity lost 16 cents this year.

Cash & shareholders

returned in FY2025 · dividends + net buybacks

Total assetsUSD 1.8M

EquityUSD 570,972.00

CashUSD 255,730.00

Current ratio0.98×

Equity funds 31% of total assets.

The 16-year record

16 fiscal years

Every figure from documents filed with the SEC · USD

row low → row highnegative—not applicable◌not available in our data

ADMT, 16-year financial record
Metric	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
Revenue $B	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Operating income $B	−0.0	−0.0	−0.0	0.0	−0.0	−0.0	−0.0	−0.0	−0.0	0.0	0.0	0.0	−0.0	−0.0	−0.0	−0.0
EBITDA $B	−0.0	−0.0	−0.0	0.0	−0.0	−0.0	0.0	−0.0	−0.0	0.0	0.0	0.0	−0.0	−0.0	−0.0	−0.0
Income tax $B	0.0	0.0	0.0	0.0	0.0	−0.0	0.0	0.0	−0.0	−0.0	◌	◌	◌	◌	−0.0	◌
Net income $B	−0.0	−0.0	−0.0	−0.0	−0.0	−0.0	−0.0	−0.0	0.0	0.0	0.0	0.0	−0.0	−0.0	−0.0	−0.0
Free cash flow $B	◌	◌	◌	◌	◌	◌	◌	◌	◌	◌	◌	◌	◌	◌	0.0	◌
EPS, diluted $	0.00	0.00	◌	◌	◌	−0.01	0.00	−0.01	0.00	0.02	0.02	0.01	0.00	−0.01	0.00	−0.01
Dividend / sh $	◌	◌	◌	◌	◌	◌	◌	◌	◌	◌	◌	◌	◌	◌	◌	◌
Payout % — not applicable: no dividend	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
ROE %	−16.2	−18.0	−77.7	−6.6	−67.0	−19.6	−2.8	−9.5	2.9	40.0	82.6	—	—	−132.9	−3.7	−93.9
Shares out B	0.07	0.07	0.07	0.07	0.07	0.07	0.07	0.07	0.07	0.07	0.07	0.06	0.06	0.06	0.06	0.06

Slide the table for earlier years. "—" not applicable · "◌" not available in our data.

Other companies filing in the same sector

MCK · COR · CAH · JNJ · HCA · LLY

Provenance

Company facts, as filed

How we verify · 0 failures in 73 reconciliationsAUDITED

Reconciled in 16 of the 16 fiscal years we could check. Six checks were skipped: the balance sheet is not tagged before 2010. Three checks were skipped: EPS is not tagged before 2010. Three checks were skipped: revenue is not tagged before 2010.

EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidityCurrency consistency0 failures

ActivityElectromedical & Electrotherapeutic Apparatus

Listed onOTC market

Incorporated inDelaware

Fiscal year endsMarch 31

SEC categorysmaller reporting company

Data on record since2010